A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity | MicrobiomeTrials← Back to trialsNCT06842186
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-01-31Est. Completion: 2027-12
Enrollment target: 400 participants Locations- Arensia Exploratory Medicine, Inc. USA, Phoenix, Arizona, United States
- Parexel International-EPCU Baltimore, Baltimore, Maryland, United States
- ARENSIA Research Clinic, Chisinau, Moldova
- Arensia Clinics S.R.L., Bucharest, Romania
- Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca, Romania
- Parexel International Early Phase Clinical Unit, Harrow, United Kingdom
- Simbec-Orion Clinical Pharmacology, Merthyr Tydfil, United Kingdom
Other microbiome trials you might be interested in
Class I/II Obesity
The goal of this clinical trial is to learn about the nature of brain abnormalities associated with excess body fat in h…
Montreal, CanadaEst. completion Dec 1, 2028
Healthy VolunteerObestity
Background:
Many people in the United States are overweight or obese. This natural history study will look into how lif…
Phoenix, United StatesEst. completion Jan 30, 2027